Cosciens Biopharma deregisters common shares with SEC, ends US reporting obligations
COSCIENS Biopharma Inc. Completes Share Capital Amendment | CSCIF Stock News
Cosciens Biopharma names Peter Puccetti full-time CEO
Cosciens Biopharma shareholders approve share capital amendment at annual meeting
COSCIENS Biopharma Inc. Reports Q1 2026 Results | CSCIF Stock News
COSCIENS Biopharma Seeks Approval for Share Capital Restructuring and Virtual AGM in June 2026